Figure 2.

(A) Status of parasite load in patients with post-kala-azar dermal leishmaniasis (PKDL). (i) Scatter plots showing the parasite load in PKDL patients with polymorphic (■; n = 85) or macular (▲; n = 72) lesions as described in Materials and Methods. Representative images of PKDL patients with polymorphic (ii) or macular (iii) lesions. (B) Effect of miltefosine on the parasite load of patients with PKDL. (i) Scatter plots indicating parasite load at disease presentation (●; n = 157) at the end of 12 weeks treatment with miltefosine (■; n = 39) and at 6 months posttreatment (▲; n = 65). Representative images of PKDL patients with persisting polymorphic (ii and iii) or macular (iv) lesions after 2 years and after 6 months, respectively.